Live Breaking News & Updates on Prnewswire Bergenbio

Stay updated with breaking news from Prnewswire bergenbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BerGenBio ASA: BerGenBio Reports Fourth Quarter 2022 Financial Results and Provides Business Update

BERGEN, Norway, Feb. 16, 2023 /PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical ....

United Kingdom , United States , Dennis Riedl , Jan Lilleby , Martin Olin , John Heymach , Tony Mok , Graham Morrell , Enriqueta Felip , Prnewswire Bergenbio , Solange Peters , Investor Relations International Media , Hebron University Hospital , Md Anderson Cancer Center , Chinese University Of Hong Kong , Department Of Oncology At Lausanne University , Department Of Clinical Oncology , Clinical Development , Oslo Stock Exchange , Chief Executive Officer , Investigator Led Study , Respiratory Infections , Acute Respiratory Distress Syndrome , Thoracic Cancer Unit , Neck Medical Oncology , Cancer Center ,

BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patie

- The Company will discuss the topline results during its Q4 2022 results presentation on Thursday, February. ....

United States , United Kingdom , City Of , Martin Olin , James Spicer , Prnewswire Bergenbio , Investor Relations International Media , Co Inc , Oslo Stock Exchange , Non Small Cell Lung Cancer , Chief Executive Officer , Experimental Cancer Medicine , College London , Principal Investigator , International Media ,

BerGenBio ASA: BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients

- The Company will discuss the topline results during its Q4 2022 results presentation on Thursday, February 16, 2023, at 10:00 AM CET - BERGEN, Norway, Feb. 15, 2023 /PRNewswire/ BerGenBio ....

United States , United Kingdom , City Of , Dennis Riedl , Graham Morrell , Jan Lilleby , Martin Olin , James Spicer , Prnewswire Bergenbio , Investor Relations International Media , Co Inc , Oslo Stock Exchange , Non Small Cell Lung Cancer , Chief Executive Officer , Experimental Cancer Medicine , College London , Principal Investigator , International Media , Abuse Regulation , Norwegian Securities Trading ,

BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients

/PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet. ....

United States , United Kingdom , City Of , Graham Morrell , Jan Lilleby , Martin Olin , James Spicer , Prnewswire Bergenbio , Investor Relations International Media , Co Inc , Oslo Stock Exchange , Non Small Cell Lung Cancer , Chief Executive Officer , Experimental Cancer Medicine , College London , Principal Investigator , International Media , Abuse Regulation , Norwegian Securities Trading , Bergenbio Asa ,

BerGenBio Announces Positive Data From Phase 2 Trial of Bemcentinib in Combination with Pembrolizumab in 2L+ NSCLC Patients

/PRNewswire/ BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet. ....

United States , United Kingdom , City Of , Graham Morrell , Jan Lilleby , Martin Olin , James Spicer , Prnewswire Bergenbio , Investor Relations International Media , Co Inc , Oslo Stock Exchange , Non Small Cell Lung Cancer , Chief Executive Officer , Experimental Cancer Medicine , College London , Principal Investigator , International Media , Abuse Regulation , Norwegian Securities Trading ,